Showing results (671-680 of 4,512) with videos related to

Sort By:
Pageof 452
Future Oncology (London, England)|July 19, 2021
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapyMatteo Ferro, Giuseppe Lucarelli, Ottavio de Cobelli, et al.
Future Oncology (London, England)|July 21, 2021
Reliability, validity and important difference estimates for the NCCN-FACT Ovarian Symptom Index-18 (NFOSI-18)Andrew Trigg, Masami Kelly, Laura Iadeluca, et al.
Future Oncology (London, England)|July 21, 2021
Real-world efficacy of docetaxel plus nintedanib after chemo-immunotherapy failure in advanced pulmonary adenocarcinomaMartin Metzenmacher, Filippo Rizzo, Kato Kambartel, et al.
Future Oncology (London, England)|July 22, 2021
Impact of chemotherapy on prognosis of resectable pathological T3N0M0 esophageal cancer patients: a population-based studyXiang Gu, Yizhi Ge, Jia Liu, et al.
Future Oncology (London, England)|May 24, 2022
FOLFIRINOX or nab-paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: an observational studyAlberto Servetto, Antonio Santaniello, Fabiana Napolitano, et al.
Future Oncology (London, England)|May 24, 2022
Indirect comparisons of brigatinib and alectinib for front-line ALK-positive non-small-cell lung cancerKaren L Reckamp, Huamao M Lin, Holly Cranmer, et al.
Future Oncology (London, England)|May 25, 2022
Pregnancy and perinatal outcomes following exposure to antineoplastic agents around pregnancy within the US FDA Adverse Event Reporting SystemOmar Abdel-Rahman, Sunita Ghosh
Future Oncology (London, England)|May 23, 2022
A phase Ib feasibility trial of response adapted neoadjuvant therapy in gastric cancer (RANT-GC)Farshid Dayyani, Brian R Smith, Ninh T Nguyen, et al.
Future Oncology (London, England)|May 11, 2022
Sarcopenic obesity in early breast cancer patients with metabolic syndrome: a cross-sectional studyGulcan Bulut, Nesrin Atci
Future Oncology (London, England)|June 30, 2021
Biosimilars in an era of rising oncology treatment optionsMarc Peeters, David Planchard, Mark Pegram, et al.
Pageof 452